Pantoprazole is a proton pump inhibitor, belongs to group of benzimidazole, Pantoprazole sodium were prepared by direct compression method using different concentration of, microcrystalline cellulose as filler, mannitol and dicalcium phosphate as diluents, crosscarmellose sodium as disintegrating agents, magnesium stearate and talc was used as a glidant and lubricant respectively. Direct compression is economic compare to wet granulation since it requires fewer unit operations. This means less equipment, lower power consumption, less space, less time and less labour leading to reduced production cost of tablets. The prepared tablets were evaluated for hardness, weight variation, friability and drug content uniformity and it was found that t...
Omaprezole is a proton pump inhibitor, antacid drug. It is categorized as class II in BCS system of ...
AbstractPantoprazole sodium sesquihydrate (PSS) is a proton pump inhibitor, used in acid-related dis...
Objective: The main objective of the present study was to formulate a fixed dose combination of chir...
Pantoprazole is a proton pump inhibitor, belongs to group of benzimidazole, Pantoprazole sodium were...
The aim of the present study is to formulate and evaluate the pantoprazole sodium enteric coated tab...
The treatment of acute diseases or a chronic illness has been mostly accomplished by delivery of dru...
Abstract: Pantoprazole is a proton pump inhibitor, belonging to the group of benzimidazoles and is u...
proton pump inhibitor belongs to group of benzimidazole. This compound inhabits gastric acid formati...
In this study, an attempt was made to deliver pantoprazole in a sustained manner using delayed relea...
AbstractPantoprazole sodium sesquihydrate (PSS) is a proton pump inhibitor, used in acid-related dis...
Background: Pantoprazole is a protein pump inhibitor (PPI) used to treat acute duodenal ulcers, acut...
Objective: Lansoprazole an proton pump inhibitor, degrades in acidic environment, hence protection o...
In an effort to reduce production costs, a simple, direct compression delayed release formulation co...
Pantoprazole is a proton pump inhibitor prodrug used in the treatment of gastric ulcers and gastroes...
Objective: The objective of this research work is to develop and evaluate the mucoadhesive gastroret...
Omaprezole is a proton pump inhibitor, antacid drug. It is categorized as class II in BCS system of ...
AbstractPantoprazole sodium sesquihydrate (PSS) is a proton pump inhibitor, used in acid-related dis...
Objective: The main objective of the present study was to formulate a fixed dose combination of chir...
Pantoprazole is a proton pump inhibitor, belongs to group of benzimidazole, Pantoprazole sodium were...
The aim of the present study is to formulate and evaluate the pantoprazole sodium enteric coated tab...
The treatment of acute diseases or a chronic illness has been mostly accomplished by delivery of dru...
Abstract: Pantoprazole is a proton pump inhibitor, belonging to the group of benzimidazoles and is u...
proton pump inhibitor belongs to group of benzimidazole. This compound inhabits gastric acid formati...
In this study, an attempt was made to deliver pantoprazole in a sustained manner using delayed relea...
AbstractPantoprazole sodium sesquihydrate (PSS) is a proton pump inhibitor, used in acid-related dis...
Background: Pantoprazole is a protein pump inhibitor (PPI) used to treat acute duodenal ulcers, acut...
Objective: Lansoprazole an proton pump inhibitor, degrades in acidic environment, hence protection o...
In an effort to reduce production costs, a simple, direct compression delayed release formulation co...
Pantoprazole is a proton pump inhibitor prodrug used in the treatment of gastric ulcers and gastroes...
Objective: The objective of this research work is to develop and evaluate the mucoadhesive gastroret...
Omaprezole is a proton pump inhibitor, antacid drug. It is categorized as class II in BCS system of ...
AbstractPantoprazole sodium sesquihydrate (PSS) is a proton pump inhibitor, used in acid-related dis...
Objective: The main objective of the present study was to formulate a fixed dose combination of chir...